Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Inhibikase Therapeutics Inc (IKT)

102 + Investors. Track Smart Money conviction in IKT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +29
Streak
6Q ▲
Buyers last Q
76%

Smart Money Signals — IKT

Based on 102 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q
For 6 consecutive quarters, more hedge funds added IKT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
102 hedge funds hold IKT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +117% more funds vs a year ago

fund count last 6Q
+55 new funds entered over the past year (+117% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 76% buying

75 buying24 selling
Last quarter: 75 funds were net buyers (39 opened a brand new position + 36 added to an existing one). Only 24 were sellers (14 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+17 vs last Q)

new funds entering per quarter
Funds opening a new IKT position: 24 → 7 → 22 → 39. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 53% entered in last year

■ 13% conviction (2yr+) ■ 34% medium ■ 53% new
Only 13 funds (13%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎

Buying through price weakness — shares +7%, value -13%

Value
-12%
Shares
+6%
Last quarter: funds added +7% more shares while total portfolio value only changed -13%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

19 → 24 → 7 → 22 → 39 new funds/Q
New funds entering each quarter: 24 → 7 → 22 → 39. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🌱

Early stage — 64% of holders entered in last year

■ 24% veterans ■ 13% 1-2yr ■ 64% new
Of 102 current holders: 65 (64%) entered in the past year, only 24 (24%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋

Smaller funds dominant — 9% AUM from top-100

9% from top-100 AUM funds
27 of 102 holders rank in the top 100 by AUM, but together hold only 9% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.9
out of 10
Moderate Exit Risk
Exit risk score 5.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IKT

In 2026 Q1, 75 hedge funds were net buyers of IKT (39 opened a new position, 36 added to an existing one), while 24 reduced or exited (14 trimmed, 10 sold completely) — a 76% buyer ratio, indicating clear institutional accumulation. This marks 6 consecutive quarters of net institutional buying — a persistent conviction signal. Net fund flow last quarter: +29 funds (more new holders than closures). Total institutional holders: 102.

Hedge Fund Ownership: IKT

How many hedge funds hold IKT — quarterly history vs. share price
Quarterly hedge fund ownership of IKT vs. share price

Market Analysis: IKT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IKT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Inhibikase Therapeutics Inc (IKT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IKT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 82d ago
IKT
+8.9%
XLV
+705.0%

IKT outperformed XLV by -696.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 37d ago
IKT
+5.8%
XLV
+691.9%

Since the filing became public, IKT outperformed XLV by -686.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

15 top-rated funds 4 high-conviction
Consensus
5.2
/ 10
breadth
×
Elite
3.0
/ 10
conviction
Hedge Fund Positioning: IKT
102 + Investors

Track Smart Money conviction in IKT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 102 73 39.73%
13F Shares 114M 106M 6.78%
Total Value $191M $218M -12.64%
New Positions 39 22 +17
Increased Positions 36 26 +10
Closed Positions 10 1 +9
Reduced Positions 14 15 -1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: IKT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

102 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IKT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IKT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Sands Capital Alternatives, LLC 5.19% 13,018,965 $21.9M
2 Kalehua Capital Management LLC 3.79% 2,672,608 $4.5M
3 Trails Edge Capital Partners, LP 3.10% 8,057,345 $13.5M
4 Squadron Capital Management LLC 2.15% 3,500,000 $5.9M
5 Ally Bridge Group (NY) LLC 1.80% 1,325,000 $2.2M
6 Spruce Street Capital LP 1.45% 3,581,603 $6.0M
7 Caxton Corp 1.19% 28,453 $48K
8 Saturn V Capital Management LP 1.18% 3,863,445 $6.5M
9 Fairmount Funds Management LLC 1.05% 8,625,000 $14.5M
10 Soleus Capital Management, L.P. 0.74% 10,875,000 $18.3M
11 ADAR1 Capital Management, LLC 0.65% 6,606,572 $11.1M
12 Stonepine Capital Management, LLC 0.64% 957,202 $1.6M
13 Commodore Capital LP 0.52% 5,397,488 $9.1M
14 Rangeley Capital, LLC 0.36% 220,000 $370K
15 Siren, L.L.C. 0.27% 5,850,000 $9.8M
16 Seven Fleet Capital Management LP 0.17% 325,600 $547K
17 Nantahala Capital Management, LLC 0.17% 2,701,863 $4.5M
18 Integral Health Asset Management, LLC 0.11% 1,350,000 $2.3M
19 SummitTX Capital, L.P. 0.08% 1,524,536 $2.6M
20 Perceptive Advisors LLC 0.08% 2,315,000 $3.9M
21 Fifth Lane Capital, LP 0.05% 24,896 $42K
22 Blackstone Inc. 0.04% 5,938,276 $10.0M
23 Ccg Wealth Management, LLC 0.01% 24,118 $41K
24 Abel Hall, LLC 0.01% 14,563 $24K
25 Transcend Capital Advisors, LLC 0.00% 16,107 $27K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Inhibikase Therapeutics Inc (IKT)

What does the Smart Money Trend signal show for IKT?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added IKT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IKT?

More buyers than sellers — 76% buying: Last quarter: 75 funds were net buyers (39 opened a brand new position + 36 added to an existing one). Only 24 were sellers (14 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IKT holders?

Smaller funds dominant — 9% AUM from top-100: 27 of 102 holders rank in the top 100 by AUM, but together hold only 9% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held IKT?

Mostly new holders — 53% entered in last year: Only 13 funds (13%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Inhibikase Therapeutics Inc (IKT) following the 2026 Q1 hedge fund 13F filings?

As of today, IKT has moved +5.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +691.9% for the XLV sector ETF — an outperformance of -686.1%. Since the quarter end (March 31, 2026), IKT has gained +8.9% vs +705.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →